大宏立(300865) - 2020 Q3 - 季度财报

Financial Performance - Operating revenue for the period was CNY 163,656,534.03, representing a 22.00% increase year-on-year[9] - Net profit attributable to shareholders decreased by 10.97% to CNY 25,857,278.44 compared to the same period last year[9] - Basic earnings per share decreased by 33.23% to CNY 0.2702[9] - The weighted average return on equity was 5.77%, down 23.68% from the previous year[9] - Total operating revenue for the current period reached ¥163,656,534.03, an increase of 22% compared to ¥134,144,043.03 in the previous period[36] - Total operating costs amounted to ¥132,820,916.64, up from ¥99,019,044.87, reflecting a 34% increase[37] - Operating profit decreased to ¥29,942,297.64 from ¥34,028,069.80, a decline of approximately 12%[38] - Net profit for the current period was ¥25,846,067.83, down from ¥29,034,024.10, representing a decrease of about 11%[39] - Total comprehensive income for the current period was ¥25,846,067.83, compared to ¥29,034,024.10 in the previous period[39] Assets and Liabilities - Total assets increased by 97.64% to CNY 1,115,493,970.57 compared to the end of the previous year[9] - The total liabilities increased to CNY 234,321,679.80 from CNY 153,410,374.01, which is an increase of about 52.7%[30] - The company's current assets totaled CNY 998,721,654.47 as of September 30, 2020, compared to CNY 444,442,910.73 at the end of 2019, indicating an increase of about 124.8%[28] - The cash and cash equivalents increased to CNY 647,794,111.77 from CNY 164,807,477.81, marking a growth of approximately 293.5%[28] - The accounts receivable rose to CNY 38,540,882.48, up from CNY 25,092,147.83, reflecting a growth of around 53.6%[28] - The company reported a significant increase in inventory, which rose to CNY 259,888,635.11 from CNY 166,692,775.63, a growth of about 55.8%[28] Shareholder Information - The total number of shareholders at the end of the reporting period was 19,368[13] - The largest shareholder, Gan Dehong, holds 36.00% of the shares, totaling 34,441,338 shares[13] Cash Flow - Net cash flow from operating activities was negative at CNY -14,286,619.27, a decrease of 143.50%[9] - The company reported a cash inflow from operating activities of CNY 551,960,842.02, compared to CNY 507,538,433.72 in the previous year, indicating a growth of 8.73%[52] - The total cash inflow from investment activities was 199,295,066.54 CNY, significantly up from 20,374,816.99 CNY, marking an increase of 877.5%[54] - The net cash flow from financing activities was 406,980,501.60 CNY, compared to a negative cash flow of 19,965,000.00 CNY in the previous period[59] - The total cash and cash equivalents at the end of the period reached 629,686,111.77 CNY, up from 52,881,027.66 CNY, indicating a substantial increase[55] Research and Development - Research and development expenses grew by 34.12% to ¥6,049,606.53, reflecting an increase in R&D personnel[17] - Research and development expenses increased slightly to ¥1,481,525.66 from ¥1,319,209.73, indicating a focus on innovation[37] - Research and development expenses increased to CNY 6,049,606.53, up 34.1% from CNY 4,510,485.74 in the same quarter last year[49] Other Income and Expenses - The company reported non-recurring gains and losses totaling CNY 5,208,723.53 for the period[11] - Other income surged by 623.45% to ¥3,408,662.95, driven by increased government subsidies[17] - Investment income rose by 50.25% to ¥1,398,436.40, due to higher returns from bank financial products[17] - The company incurred credit impairment losses of CNY -3,865,716.73, compared to CNY -969,346.18 in Q3 2019, indicating a significant increase in credit losses[49] Dividend Policy - The company has no significant changes in its cash dividend policy or any violations regarding external guarantees during the reporting period[20][21] - The company paid 22,000,000.00 CNY in dividends, an increase from 18,000,000.00 CNY in the previous period[55]